Savers Value Village CEO Walsh exercises options and sells 4,096 shares under 10b5-1
Rhea-AI Filing Summary
Mark T. Walsh, CEO and Director of Savers Value Village, Inc. (SVV), reported option exercise and an offsetting sale on 09/11/2025. He exercised 4,096 options with an exercise price of $1.41 per share, producing 4,096 shares acquired. Those same 4,096 shares were sold under a 10b5-1 plan adopted May 19, 2025, at a weighted-average sale price of $13.0174 per share, with trade executions ranging from $13.00 to $13.04. Following these transactions, the report shows Mr. Walsh beneficially owns 2,104,710 shares directly. The exercised options originated from an October 7, 2019 grant that fully vested on October 7, 2024; approximately 37% of the options were time-based and 63% performance-based.
Positive
- Transactions executed under a documented 10b5-1 plan (adopted May 19, 2025), which provides pre-specified trading parameters.
- Options fully vested from the October 7, 2019 grant (fully vested on October 7, 2024), with vesting breakdown disclosed (~37% time-based, ~63% performance-based).
- Full disclosure of sale pricing including weighted-average price ($13.0174) and execution range ($13.00 to $13.04) and offer to provide per-price execution details upon request.
Negative
- Insider sale of 4,096 shares was reported, which may be perceived negatively by some investors despite being under a 10b5-1 plan.
- After the reported sale, the filing lists zero beneficial ownership for the 4,096 shares sold (the report shows the sold shares no longer held), indicating a reduction in that tranche of holdings.
Insights
TL;DR: Insider exercised options and sold the same number of shares under a pre-established 10b5-1 plan; overall direct beneficial ownership remains material.
The filing documents a routine post-vesting exercise and contemporaneous sale executed pursuant to a 10b5-1 trading plan, with an exercise price of $1.41 and a weighted-average sale price of $13.0174 for 4,096 shares. The filing discloses full vesting of the October 2019 option grant as of October 7, 2024 and quantifies the split between time-based and performance-based options. From a market-impact perspective, the sizes reported are small relative to institutional blocks but meaningful for disclosure: the reporting person retains 2,104,710 shares of common stock after these transactions.
TL;DR: Transaction follows an adopted 10b5-1 plan and documents vesting terms; disclosure appears complete and procedurally conforming.
The report includes the required explanatory information: adoption date of the 10b5-1 plan, weighted-average sale price and price range, and vesting schedule details for the 2019 option grant. Signature by attorney-in-fact is provided. The filing explains the composition of the option award (approx. 37% time-based, 63% performance-based) and the performance-based vesting linkage to IPO and further stock-price criteria. From a governance standpoint, the filing supplies the detail investors and regulators expect for insider transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (Right to Purchase) | 4,096 | $1.41 | $6K |
| Exercise | Common Stock | 4,096 | $1.41 | $6K |
| Sale | Common Stock | 4,096 | $13.0174 | $53K |
Footnotes (1)
- The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on May 19, 2025. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $13.00 to $13.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. Approximately 37% represents time-based options which vested in substantially equal annual installments over five years starting October 7, 2020 and approximately 63% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.
